117 related articles for article (PubMed ID: 38561035)
1. APLN promotes the proliferation, migration, and glycolysis of cervical cancer through the PI3K/AKT/mTOR pathway.
Wang Q; Wang B; Zhang W; Zhang T; Liu Q; Jiao X; Ye J; Hao Y; Gao Q; Ma G; Hao C; Cui B
Arch Biochem Biophys; 2024 May; 755():109983. PubMed ID: 38561035
[TBL] [Abstract][Full Text] [Related]
2. APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is a druggable target.
Chen H; Wong CC; Liu D; Go MYY; Wu B; Peng S; Kuang M; Wong N; Yu J
Theranostics; 2019; 9(18):5246-5260. PubMed ID: 31410213
[No Abstract] [Full Text] [Related]
3. The Apelin-Apelin Receptor Axis Triggers Cholangiocyte Proliferation and Liver Fibrosis During Mouse Models of Cholestasis.
Chen L; Zhou T; White T; O'Brien A; Chakraborty S; Liangpunsakul S; Yang Z; Kennedy L; Saxena R; Wu C; Meng F; Huang Q; Francis H; Alpini G; Glaser S
Hepatology; 2021 Jun; 73(6):2411-2428. PubMed ID: 32964473
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of APLN suppresses cell proliferation and migration and promotes cell apoptosis in esophageal cancer cells in vitro, through activating PI3K/mTOR signaling pathway.
Wang Y; Wang G; Liu X; Yun D; Cui Q; Wu X; Lu W; Yang X; Zhang M
Eur J Histochem; 2022 Aug; 66(3):. PubMed ID: 35920446
[TBL] [Abstract][Full Text] [Related]
5. Apelin (APLN) and Apelin Receptor (APLNR) in Human Ovary: Expression, Signaling, and Regulation of Steroidogenesis in Primary Human Luteinized Granulosa Cells.
Roche J; Ramé C; Reverchon M; Mellouk N; Cornuau M; Guerif F; Froment P; Dupont J
Biol Reprod; 2016 Nov; 95(5):104. PubMed ID: 27683264
[TBL] [Abstract][Full Text] [Related]
6. LINC00941 promoted in vitro progression and glycolysis of laryngocarcinoma by upregulating PKM via activating the PI3K/AKT/mTOR signaling pathway.
Li Z; Jin Q; Sun Y
J Clin Lab Anal; 2022 Jul; 36(7):e24406. PubMed ID: 35588431
[TBL] [Abstract][Full Text] [Related]
7. KIFC3 Promotes Proliferation, Migration, and Invasion in Colorectal Cancer
Liao H; Zhang L; Lu S; Li W; Dong W
Front Genet; 2022; 13():848926. PubMed ID: 35812733
[No Abstract] [Full Text] [Related]
8. PTPRH promotes the progression of non-small cell lung cancer via glycolysis mediated by the PI3K/AKT/mTOR signaling pathway.
Wang S; Cheng Z; Cui Y; Xu S; Luan Q; Jing S; Du B; Li X; Li Y
J Transl Med; 2023 Nov; 21(1):819. PubMed ID: 37974250
[TBL] [Abstract][Full Text] [Related]
9. G6PC indicated poor prognosis in cervical cancer and promoted cervical carcinogenesis in vitro and in vivo.
Zhu K; Deng C; Du P; Liu T; Piao J; Piao Y; Yang M; Chen L
Reprod Biol Endocrinol; 2022 Mar; 20(1):50. PubMed ID: 35277194
[TBL] [Abstract][Full Text] [Related]
10. Actin-Like Protein 8 Promotes the Progression of Triple-Negative Breast Cancer via Activating PI3K/AKT/mTOR Pathway.
Fan S; Yan S; Yang Y; Shang J; Hao M
Onco Targets Ther; 2021; 14():2463-2473. PubMed ID: 33883901
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851
[TBL] [Abstract][Full Text] [Related]
12. [LncRNA SNHG11 promotes malignant progression of colorectal cancer cells through the PI3K/Akt/mTOR signaling pathway].
Tao SN; Liu XC; Wang YY; Yang H
Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(10):758-765. PubMed ID: 38462356
[No Abstract] [Full Text] [Related]
13. Long noncoding RNA KB-1980E6.3 promotes breast cancer progression through the PI3K/AKT signalling pathway.
He L; Tang L; Wang R; Liu L; Zhu P; Jiang K; Tu G
Pathol Res Pract; 2022 Jun; 234():153891. PubMed ID: 35461041
[TBL] [Abstract][Full Text] [Related]
14. SIK2 Promotes Cisplatin Resistance Induced by Aerobic Glycolysis in Breast Cancer Cells through PI3K/AKT/mTOR Signaling Pathway.
Zong S; Dai W; Fang W; Guo X; Wang K
Biosci Rep; 2020 May; ():. PubMed ID: 32458975
[TBL] [Abstract][Full Text] [Related]
15. KIAA0101 knockdown inhibits glioma progression and glycolysis by inactivating the PI3K/AKT/mTOR pathway.
Wang K; Li J; Zhou B
Metab Brain Dis; 2022 Feb; 37(2):489-499. PubMed ID: 34792707
[TBL] [Abstract][Full Text] [Related]
16. Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway.
Yin F; Huang X; Xuan Y
Dis Markers; 2021; 2021():9950663. PubMed ID: 34512817
[TBL] [Abstract][Full Text] [Related]
17. CDK12 Promotes the Proliferation, Migration, and Angiogenesis of Gastric Carcinoma via Activating the PI3K/AKT/mTOR Signaling Pathway.
Gao LZ; Wang JQ; Chen JL; Zhang XL; Zhang MM; Wang SL; Zhao C
Appl Biochem Biotechnol; 2023 Nov; 195(11):6913-6926. PubMed ID: 36951936
[TBL] [Abstract][Full Text] [Related]
18. High APLN Expression Predicts Poor Prognosis for Glioma Patients.
Lv S; An Y; Dong H; Xie L; Zheng H; Cheng X; Zhang L; Teng T; Wang Q; Yan Z; Guo X
Oxid Med Cell Longev; 2022; 2022():8393336. PubMed ID: 36193059
[TBL] [Abstract][Full Text] [Related]
19. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
[TBL] [Abstract][Full Text] [Related]
20. SKA3 promotes cell proliferation and migration in cervical cancer by activating the PI3K/Akt signaling pathway.
Hu R; Wang MQ; Niu WB; Wang YJ; Liu YY; Liu LY; Wang M; Zhong J; You HY; Wu XH; Deng N; Lu L; Wei LB
Cancer Cell Int; 2018; 18():183. PubMed ID: 30459531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]